Target intelligence / Profile preview

Haptocorrin (HC)

Target
HC
Molecular classification
Transcobalamin glycoprotein, Cobalamin-binding protein, Transport protein
01

Overview

Haptocorrin, also known as Transcobalamin-1 or R-binder, is a heavily glycosylated protein encoded by the TCN1 gene that plays a critical role in the transport and protection of Vitamin B12 (cobalamin). Produced primarily by salivary glands and found in various secretions and plasma, it binds Vitamin B12 with high affinity to protect it from degradation by gastric acid in the stomach. In the duodenum, haptocorrin is degraded by pancreatic proteases, allowing the released Vitamin B12 to bind to Intrinsic Factor for intestinal absorption. Beyond its physiological role in B12 metabolism, haptocorrin serves as a diagnostic biomarker for myeloproliferative disorders and certain cancers, such as fibrolamellar hepatocellular carcinoma, where its levels are significantly elevated. Recent therapeutic strategies explore haptocorrin as a vehicle for drug delivery, utilizing its binding capacity to improve the pharmacokinetics and half-life of conjugated peptide drugs.

Other names
Transcobalamin-1Transcobalamin ITCN1R-binderR-proteinCobalophilinSalivary R-factor
02

Mechanism of action

Haptocorrin binds dietary Vitamin B12 in the oral cavity and stomach with high affinity, forming a complex that is resistant to low pH, thereby protecting the vitamin from acid-induced denaturation. In the duodenum, the protein is degraded by pancreatic proteases, releasing the vitamin for subsequent binding to Intrinsic Factor.

03

Biological functions

Vitamin B12 transportProtection of cobalamin from gastric acid degradationSequestration of cobalamin analogsAntimicrobial activityCirculating storage of cobalamin
04

Disease associations

Vitamin B12 deficiencyMyeloproliferative disordersFibrolamellar hepatocellular carcinomaBreast cancerMegaloblastic anemia
05

Safety considerations

Elevated haptocorrin can cause falsely high serum B12 readings, masking functional deficiencyGenetic deficiency leads to low serum B12 levels (pseudodeficiency)Potential for B12 malabsorption in cases of severe haptocorrin depletion
06

Interacting drugs

Cyanocobalamin

4 more in the full profile.

07

Biomarkers

Serum haptocorrin levelHolohaptocorrin (holoHC)Total transcobalamin I

Beyond the preview

Go deeper on Haptocorrin (HC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haptocorrin (HC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call